SGC-CAF382-1
CAF-382 (compound B1) is an analog of SNS-032 and a CDKL5 and pan-CDK inhibitor with a weak GSK3α/β affinity (>1.8 μM) and inhibitory activity. CAF-382 inhibits CDKL5 and blocks the phosphorylation of the CDKL5 E2 domain[1].
Product Specifications
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/caf-382.html
Purity
99.85
Solubility
10 mM in DMSO
Smiles
CC(C1=CN=C(O1)CSC2=CN=C(S2)NC(C3CCNCC3)=O)C
Molecular Formula
C16H22N4O2S2
Molecular Weight
366.50
References & Citations
[1]Castano A, et al. Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin-dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiology. Elife. 2023 Jul 25;12:e88206.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
EKC32674 96 Tests
Human Anti-Granulocyte-Macrophage Colony Stimulating Factor (Gm-Csf) Antibody Elisa Kit
Sign In for Pricing
View Details